Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 258564Erstellt: 24. Oktober 2026

1-Acetyl-6-aminoindoline

NSC 87623 · 1-ACETYLINDOLIN-6-AMINE · 6-Amino-N-acetylindoline · 1-Acetyl-6-aminoindoline · 1-Acetyl-6-aminoindoline 95+% · 1-(6-Aminoindolin-1-yl)ethanone · 1-(6-amino-1-indolinyl)ethanone · 1-Acetyl-6-aminoindoline powder

https://huagongshe.com/de/chemical/258564

Molekülstruktur von 1-Acetyl-6-aminoindoline

Identifikatoren & physikalische Daten

CAS No.62368-29-0
SummenformelC10H12N2O
Durchschnittliche Molmasse176,21 g/mol
Monoisotopische Masse176,094963 g/mol
SMILESCC(=O)N1CCc2ccc(N)cc21
InChIKeyLOZKZWIQDVEDCQ-UHFFFAOYSA-N
PubChem CID258564
ChEMBLCHEMBL1877102
EC No.622-695-5
DTXSIDDTXSID00293172

Chemische & physikalische Eigenschaften

XLogP0,6
Polarare Oberfläche (TPSA)46,3
H-Brücken-Donoren1
H-Brücken-Akzeptoren2
Frei drehbare Bindungen0
Schwere Atome13
Formalladung0
Komplexität217
Schmelzpunkt182 °C
Lagerbedingungen2-8°C
Aggregatzustandpowder
Farbeyellow to tan
InChI1S/C10H12N2O/c1-7(13)12-5-4-8-2-3-9(11)6-10(8)12/h2-3,6H,4-5,11H2,1H3
InChIKeyLOZKZWIQDVEDCQ-UHFFFAOYSA-N
SMILESCC(=O)N1CCc2ccc(N)cc12

Sicherheit & Vorschriften

GHS-EinstufungWarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P330, P337+P317, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 42 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (100%)
Wassergefährdungsklasse (WGK)3
Zollcode2933998090
R-Sätze (R)22
GefahrensymboleXn,Xi
hazard_noteIrritant
Lagerklasse11 - Combustible Solids
GefahrenklasseAcute Tox. 4 Oral

Anwendungen & Verwendung

Verwenden

Reactant for preparation of:Transient receptor potential cation channel V1 (TRPV1) antagonistsInhibitor of the human immunodeficiency virus (HIV) envelope glycoprotein gp120 binding to the cluster of differentiation 4 (CD4) receptorAntiproliferative agentsSerotonin 5-HT2C/2B receptor antagonists